US EditionEU-US trade deal could add up to $19 billion in pharma industry costs, analysts say
UNITED STATES, JUL 29 – The EU-US trade deal imposes a 15% tariff on pharmaceuticals, risking up to $19 billion in added costs for the pharma industry, while averting a harsher 30% tariff, analysts said.
- The European Union and United States struck a trade deal over the weekend including a 15% tariff on most pharmaceutical imports to the U.S.
- The deal arose amid ongoing U.S. national security investigations into pharmaceuticals and conflicting claims about tariff exclusions for medicines.
- European officials confirmed the tariff applies broadly except for certain generics, while companies are stockpiling inventory to mitigate disruption and firms face uncertainty.
- Analysts estimate the tariffs could add $13 billion to $19 billion in costs to the pharma industry and increase prices for U.S. consumers, with EFPIA warning tariffs will harm innovation and patient access.
- The deal requires member state ratification and faces political backlash in Europe, suggesting significant economic challenges ahead for the EU pharma sector and potential shifts in production strategies.
52 Articles
52 Articles
997wpro.com
NewsmaxUS-EU Trade Deal Could Affect Drug Prices
The pharmaceutical industry's fear of being hit with extremely high levies related to national security was soothed by President Donald Trump's trade deal with the European Union, according to reports. The trade agreement will impose a 15% tariff on imported medicines from Europe. That's much lower than the taxes of up to 200% Trump had threatened, The New York Times reported. Despite the lower percentage, the tariffs are expected to add billion…
EU-US trade deal could add up to $19B in pharma industry costs, analysts say - West Hawaii Today
The European Union’s trade deal with the United States could cost the pharmaceutical industry between $13 billion and $19 billion as branded medicines become subject to a tariff of 15%, analysts said on Monday.
EU leaders express frustration with US trade deal
The European Union’s trade deal with the US was met with frustration and resignation rather than celebration within the bloc. Germany’s chancellor said it would “substantially damage” the finances of the EU’s biggest economy, and France’s prime minister called it a “submission,” with even those who supported the deal doing so in lukewarm fashion: Spain’s prime minister said he backed it “without any enthusiasm,” and the leader of European Commis…
Coverage Details
Bias Distribution
- 44% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
